Vocal Biomarkers Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Vocal Biomarkers Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).


Learn More On The Vocal Biomarkers Market:
https://www.thebusinessresearchcompany.com/report/vocal-biomarkers-global-market-report

According to The Business Research Company’s Vocal Biomarkers Global Market Report 2024, The vocal biomarkers market size is expected to see exponential growth in the next few years. It will grow to $5.63 billion in 2028 at a compound annual growth rate (CAGR) of 18.6%.  The growth in the forecast period can be attributed to rising cases of neurological and psychological disorders, high demand for novel diagnostic procedures, a growing incidence of dementia, increasing awareness about the efficacy of vocal biomarkers, and increasing diagnostic procedures. Major trends in the forecast period include advancements in biomarker technology, rapid adoption of advanced technologies, high investments in R&D, improvements in diagnostic capabilities, and advanced technology in the medical industry.

The rising cases of neurological and psychological disorders are expected to propel the growth of the voice biomarkers market going forward. Neurological disorders are medical conditions affecting the nervous system, whereas psychological disorders are conditions that impact mood, thinking, and behavior. The increasing cases of neurological and psychological disorders can be attributed to factors such as increased stress, aging populations, lifestyle changes, and greater awareness and diagnosis capabilities. Neurological and psychological disorders use voice biomarkers to non-invasively detect and monitor disease-specific changes in speech patterns, pitch, and rhythm, providing valuable insights into the presence and progression of these conditions. For instance, in April 2024, according to the data published by alzheimers.gov, a US-based Department of Health and Human Services (HHS), more than 6 million Americans aged 65 and older are living with Alzheimer’s disease in 2024, and it is predicted that this number will increase to more than 13 million people by 2060. Additionally, in April 2021, according to the Centers for Disease Control and Prevention, a US-based national public health agency, from August 2020 to February 2021, the percentage of adults experiencing symptoms of anxiety or depressive disorders rose from 36.4% to 41.5%. Therefore, the rising cases of neurological and psychological disorders are driving the growth of the voice biomarkers market going forward.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=17294&type=smp

The vocal biomarkers market covered in this report is segmented –
1) By Type: Frequency, Amplitude, Error Rate, Vocal Rise Or Fall Time, Phonation Time, Voice Tremor, Pitch, Other Types
2) By Indications: Psychiatric Disorders, Neurological Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Other Indications
3) By Consumer: Children And Newborns, Adult
4) By End Users: Hospitals And Clinics, Academic, Research, Other End-Users

Major companies operating in the vocal biomarkers market are focusing on developing advanced technology, such as voice-enabled technology, to enhance diagnostic accuracy, improve patient monitoring, and enable early detection of various medical conditions. Voice-enabled technology aims to help individuals better understand their mental state and encourage proactive engagement with mental health services. For instance, in October 2021, Sonde Health Inc., a US-based health technology company, launched Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology. The technology analyzes vocal features such as smoothness, control, liveliness, energy range, and clarity to detect changes that could indicate conditions such as depression, stress, anxiety, and fatigue. This demonstrates the company's leadership in the vocal biomarker market and the growing potential for voice-based technologies to transform health monitoring and management, particularly in the critical area of mental health

The vocal biomarkers market report table of contents includes:
1. Executive Summary
2. Vocal Biomarkers Market Characteristics
3. Vocal Biomarkers Market Trends And Strategies
4. Vocal Biomarkers Market - Macro Economic Scenario
5. Global Vocal Biomarkers Market Size and Growth
……………
32. Global Vocal Biomarkers Market Competitive Benchmarking
33. Global Vocal Biomarkers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Vocal Biomarkers Market
35. Vocal Biomarkers Market Future Outlook and Potential Analysis
36. Appendix